|

ALN-SNCA Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Regeneron Pharmaceuticals1

Indications

  • Parkinsons Disease1
  • Parkinson's Disease1

Other1 trial

First-in-Human Study of ALN-SNCA in Adult Participants With Early Parkinson's Disease (PD)
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.